{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:20:53Z","timestamp":1782922853021,"version":"3.54.5"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ejogrb.2016.12.008","type":"journal-article","created":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T07:17:54Z","timestamp":1481267874000},"page":"126-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The impact of highly active antiretroviral therapy on obstetric conditions: A review"],"prefix":"10.1016","volume":"210","author":[{"given":"Hannah M.","family":"Sebitloane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhayendre","family":"Moodley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2016.12.008_bib0005","unstructured":"National Committee for Confidential Enquiry into Maternal Deaths. Saving Mothers 2011\u20132013: Sixth report on the Confidential Enquiries into Maternal Deaths in South Africa. http:\/\/www.kznhealth.gov.za\/mcwh\/Maternal\/Saving-Mothers-2011-2013-short-report.pdf. Published 2014. (Accessed 3 June 2016)."},{"issue":"14","key":"10.1016\/j.ejogrb.2016.12.008_bib0010","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1097\/00002030-200109280-00016","article-title":"Maternal mortality associated with tuberculosis-HIV-1 co-infection in Durban, South Africa","volume":"15","author":"Khan","year":"2001","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.ejogrb.2016.12.008_bib0015","first-page":"675","article-title":"A study of maternal mortality at the University Teaching Hospital Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death","volume":"3","author":"Ahmed","year":"1999","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"10.1016\/j.ejogrb.2016.12.008_bib0020","first-page":"11","article-title":"A systematic review of interventions to reduce maternal mortality among HIV-Infected pregnant and postpartum women","volume":"4","author":"Holtz","year":"2015","journal-title":"Int J MCH AIDS"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0025","series-title":"The global prevalence of anaemia in 2011","author":"WHO","year":"2015"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1155\/2014\/849080","article-title":"Prevalence of anaemia among pregnant women at booking in the University of Uyo Teaching Hospital, Uyo, Nigeria","volume":"2014","author":"Olatunbosun","year":"2014","journal-title":"BioMed Res Int"},{"issue":"5\u20136","key":"10.1016\/j.ejogrb.2016.12.008_bib0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s002770050340","article-title":"Pathogenesis and pathophysiology of anemia in HIV infection","volume":"75","author":"Kreuzer","year":"1997","journal-title":"Ann Hematol."},{"issue":"9","key":"10.1016\/j.ejogrb.2016.12.008_bib0040","doi-asserted-by":"crossref","first-page":"e106103","DOI":"10.1371\/journal.pone.0106103","article-title":"Anaemia in pregnancy is associated with advanced HIV disease","volume":"9","author":"Nandlal","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejogrb.2016.12.008_bib0045","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1600-0609.1992.tb00591.x","article-title":"Epidemiology of thrombocytopenia in HIV infection","volume":"48","author":"Sloand","year":"1992","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1016\/j.ejogrb.2016.12.008_bib0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.7196\/SAMJ.2016.v106i2.9903","article-title":"Thrombocytopenia during pregnancy in women with HIV infection receiving no treatment","volume":"106","author":"Sebitloane","year":"2016","journal-title":"S Afr Med J"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0055","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(96)07493-4","article-title":"Mortality by cause for eight regions of the world: global burden of disease study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0060","first-page":"363","article-title":"Sebitloane HM.HIV-associated maternal mortality \u2212primary causes of death at King Edward VIII Hospital, Durban","volume":"97","author":"Ramogale","year":"2007","journal-title":"S Afr Med J"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0065","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1097\/QAI.0b013e31821ac9c1","article-title":"Active tuberculosis case-finding among pregnant women presenting to antenatal clinics in Soweto, South Africa","volume":"57","author":"Gounder","year":"2011","journal-title":"J Acquir Immun Defic Syndr"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0070","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1097\/01.aids.0000244201.11006.1c","article-title":"Hospitalizations of pregnant HIV-infected women in the USA prior to and during the era of HAART, 1994\u20132003","author":"Kourtis","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.05.048","article-title":"Trends in hospitalizations of pregnant HIV-infected women in the United States: 2004 through 2011","author":"Ewing","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0080","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0020-7292(00)00364-7","article-title":"Active management of labor: is it suitable for a developing country","volume":"72","author":"Chanrachakul","year":"2001","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"10","key":"10.1016\/j.ejogrb.2016.12.008_bib0085","doi-asserted-by":"crossref","first-page":"e74848","DOI":"10.1371\/journal.pone.0074848","article-title":"HIV and the risk of direct obstetric complications: a systematic review and meta-Analysis","volume":"8","author":"Calvert","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0090","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ijgo.2016.02.012","article-title":"Increasing maternal deaths due to obstetric hemorrhage in a setting of high HIV seroprevalence","volume":"134","author":"Sebitloane","year":"2016","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1258\/td.2007.070081","article-title":"HIV and obstetric complications and fetal outcomes in Vellore, India","volume":"38","author":"Lionel","year":"2008","journal-title":"Trop Doct"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijgo.2010.05.023","article-title":"Term labor management and outcomes in treated HIV-infected women without contraindications to vaginal delivery and matched controls","volume":"111","author":"Azria","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"issue":"5","key":"10.1016\/j.ejogrb.2016.12.008_bib0105","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/MBC.0000000000000066","article-title":"Haemostatic trends in HIV-infected individuals in Yaound\u00e9, Cameroon: a pilot study","volume":"25","author":"Tene","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0110","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bpobgyn.2011.01.005","article-title":"The origins and end-organ consequence of pre-eclampsia","volume":"25","author":"Eastabrook","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"9340","key":"10.1016\/j.ejogrb.2016.12.008_bib0115","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0140-6736(02)11195-0","article-title":"Pre-eclampsia, antiretroviral therapy, and immune reconstitution","volume":"360","author":"Wimalasundera","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejogrb.2016.12.008_bib0120","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejogrb.2004.04.014","article-title":"Preeclampsia and HIV infection","volume":"117","author":"Mattar","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/QAI.0000000000000686","article-title":"HIV, antiretroviral therapy hypertensive disorders in pregnancy: a systematic review and meta-analysis","volume":"70","author":"Browne","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.preghy.2016.04.006","article-title":"Antiretrovirals causing severe pre-eclampsia","author":"Tooke","year":"2016","journal-title":"Preg Hyper: Int J Women\u2019s Card Health"},{"issue":"6","key":"10.1016\/j.ejogrb.2016.12.008_bib0135","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jinf.2013.12.018","article-title":"Hypertension, preeclampsia and eclampsia among HIV-infected pregnant women from Latin America and Caribbean countries","volume":"68","author":"Machado","year":"2014","journal-title":"J Infect"},{"issue":"315","key":"10.1016\/j.ejogrb.2016.12.008_bib0140","first-page":"e1","article-title":"Obstetric and newborn infant outcomes in human immunodeficiency virus\u2013infected women who receive highly active antiretroviral therapy","volume":"201","author":"Haeri","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0145","unstructured":"H.M. Sebitloane, J. Moodley, B. Sartorius, The relationship between HIV infection and Preeclampsia: the impact of immunosuppression and the restorative effect of HAART \u2212unpublished data."},{"issue":"189","key":"10.1016\/j.ejogrb.2016.12.008_bib0150","first-page":"e181","article-title":"Prophylactic antibiotics for the prevention of postpartum infectious morbidity in women infected with human immunodeficiency virus: a randomized controlled trial","volume":"198","author":"Sebitloane","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.ejogrb.2016.12.008_bib0155","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00002030-200404090-00011","article-title":"Higher rates of post-partum complications in HIVinfected than in uninfected women irrespective of mode of delivery","volume":"18","author":"Fiore","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0160","first-page":"362","article-title":"Pregnancy outcome in women infected with the human immunodeficiency virus","volume":"41","author":"Figueroa-Damian","year":"1999","journal-title":"Salud Publica Mex"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0165","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199904013401301","article-title":"The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1. A meta-analysis of 15 prospective cohort studies","volume":"340","author":"The International Perinatal HIV Group","year":"1999","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejogrb.2016.12.008_bib0170","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1086\/427287","article-title":"Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy","volume":"40","author":"European Collaborative Study","year":"2005","journal-title":"Clin Infect Dis."},{"issue":"2","key":"10.1016\/j.ejogrb.2016.12.008_bib0175","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1471-0528.2006.01183.x","article-title":"The AmRo study: pregnancy outcome in HIV-1- infected women under effective highly active antiretroviral therapy and a policy of vaginal delivery","volume":"114","author":"Boer","year":"2007","journal-title":"BJOG"},{"issue":"2","key":"10.1016\/j.ejogrb.2016.12.008_bib0180","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1080\/20786204.2013.10874326","article-title":"Is there still a role for Caesarean section in preventing vertical HIV transmission in the era of highly active antiretroviral therapy?","volume":"55","author":"Sebitloane","year":"2013","journal-title":"S Afr Fam Pract"},{"issue":"2","key":"10.1016\/j.ejogrb.2016.12.008_bib0185","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/QAD.0b013e3282f3d63c","article-title":"ANRS french perinatal cohort: mother-to-child HIV transmission despite antiretroviral therapy in the ANRS french perinatal cohort","volume":"22","author":"Warszawski","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0190","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/QAI.0b013e31802ea4b0","article-title":"Pregnancy outcomes in HIV-Infected and uninfected women in rural and urban South Africa","volume":"44","author":"Rollins","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0195","unstructured":"Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States (downloaded from http:\/\/aidsinfo.nih.gov\/guidelines. on 11\/30\/2016)."},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0200","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/QAD.0000000000000212","article-title":"Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000\u20132011","volume":"28","author":"Townsend","year":"2014","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.ejogrb.2016.12.008_bib0205","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1093\/humrep\/des090","article-title":"Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa","volume":"27","author":"Ndirangu","year":"2012","journal-title":"Hum Reproduct (Oxford, England)"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0210","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s12884-015-0684-z","article-title":"Association between maternal HIV infection and low birth weight and prematurity: a meta-analysis of cohort studies","volume":"15","author":"Xiao","year":"2015","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0215","doi-asserted-by":"crossref","first-page":"836 8","DOI":"10.1111\/j.1471-0528.1998.tb10227.x","article-title":"The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis","volume":"105","author":"Brocklehurst","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"5","key":"10.1016\/j.ejogrb.2016.12.008_bib0220","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/QAD.0b013e32802ef2f6","article-title":"Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis","volume":"21","author":"Kourtis","year":"2007","journal-title":"AIDS (London, England)"},{"issue":"1","key":"10.1016\/j.ejogrb.2016.12.008_bib0225","first-page":"31","article-title":"Antiretroviral therapy and pregnancy outcomes in developing countries: a systematic review","volume":"3","author":"Alemu","year":"2015","journal-title":"Int J MCH AIDS"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0230","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12884-016-0821-3","article-title":"Improved pregnancy outcomes with increasing antiretroviral coverage in South Africa: moodley et al","volume":"16","author":"Moodley","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0235","series-title":"CROI","article-title":"PROMISE: Efficacy and safety of 2 strategies to prevent perinatal HIV transmission","author":"Fowler","year":"2015"},{"issue":"4\u20136","key":"10.1016\/j.ejogrb.2016.12.008_bib0240","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/15257771003741018","article-title":"Identification and characterization of mitochondrial factors modulating thymidine kinase 2 activity","volume":"29","author":"Sun","year":"2010","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0245","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(99)80008-7","article-title":"Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala,;1; Uganda: HIVNET 012 randomised trial","volume":"354","author":"Guay","year":"1999","journal-title":"Lancet"},{"issue":"Pt 1 (11)","key":"10.1016\/j.ejogrb.2016.12.008_bib0250","doi-asserted-by":"crossref","first-page":"855","DOI":"10.7196\/SAMJ.5700","article-title":"Safety of nevirapine in HIV-infected pregnant women initiating antiretroviral therapy at higher CD4 counts: a systematic review and meta-analysis","volume":"102","author":"Bera","year":"2012","journal-title":"S Afr Med J"},{"issue":"Suppl. 2","key":"10.1016\/j.ejogrb.2016.12.008_bib0255","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/QAD.0000000000000231","article-title":"Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis","volume":"28","author":"Ford","year":"2014","journal-title":"AIDS"},{"issue":"July (2)","key":"10.1016\/j.ejogrb.2016.12.008_bib0260","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1086\/518976","article-title":"A high incidence of lactic acidosis and symptomatic hyperlactatemia in women receiving highly active antiretroviral therapy in Soweto","volume":"45","author":"Bolhaar","year":"2007","journal-title":"South Africa Clin Infect Dis"},{"key":"10.1016\/j.ejogrb.2016.12.008_bib0265","doi-asserted-by":"crossref","unstructured":"V. Black, R.M. Hoffman, C.A. Sugar, et al., Safety and Efficacy of Initiating Highly Active Antiretroviral Therapy in an Integrated Antenatal and HIV Clinic in Johannesburg, South Africa, Published in final edited form as: J Acquir Immune Defic Syndr. 2008 49 3 276\u2013281. http:\/\/dx.doi.org\/10.1097\/QAI.0b013e318189a769.","DOI":"10.1097\/QAI.0b013e318189a769"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211516310673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211516310673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T15:02:29Z","timestamp":1779807749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211516310673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":53,"alternative-id":["S0301211516310673"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2016.12.008","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of highly active antiretroviral therapy on obstetric conditions: A review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2016.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}